ASPM promotes hepatocellular carcinoma progression by activating Wnt/β-catenin signaling through antagonizing autophagy-mediated Dvl2 degradation.
Haifeng ZhangXiaobei YangLili ZhuZhihui LiPeipei ZuoPeng WangJingyu FengYang MiChengjuan ZhangYan XuGe JinJianying ZhangHua YePublished in: FEBS open bio (2021)
Hepatocellular carcinoma (HCC) is one of the most fatal cancers worldwide. In this article, we show that expression of abnormal spindle-like microcephaly-associated protein (ASPM) is up-regulated in liver cancer samples, and this up-regulation is significantly associated with tumor aggressiveness and reduced survival times of patients. Down-regulation of ASPM expression inhibits the proliferation, invasion, migration and epithelial-to-mesenchymal transition of HCC cells in vitro and inhibits tumor formation in nude mice. ASPM interacts with disheveled-2 (Dvl2) and antagonizes autophagy-mediated Dvl2 degradation by weakening the functional interaction between Dvl2 and the lipidated form of microtubule-associated proteins 1A/1B light chain 3A (LC3II), thereby increasing Dvl2 protein abundance and leading to Wnt/β-catenin signaling activation in HCC cells. Thus, our results define ASPM as a novel oncoprotein in HCC and indicate that disruption of the Wnt-ASPM-Dvl2-β-catenin signaling axis might have potential clinical value.
Keyphrases
- induced apoptosis
- signaling pathway
- endoplasmic reticulum stress
- cell cycle arrest
- poor prognosis
- cell death
- stem cells
- cell proliferation
- binding protein
- oxidative stress
- end stage renal disease
- ejection fraction
- zika virus
- pi k akt
- intellectual disability
- peritoneal dialysis
- mass spectrometry
- transcription factor
- risk assessment
- type diabetes
- prognostic factors
- adipose tissue
- cell migration
- microbial community
- simultaneous determination
- climate change
- skeletal muscle
- liquid chromatography